Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The nasal mucosal barrier is a complex, multilayered system in the nasal cavity that consists of physical (cell junctions, epithelial cells), chemical (mucus, cilia), immune (immunoglobulins, antimicrobial proteins), and microbiological (commensal microbiota) defenses[1][2][3][4]. This barrier prevents the entry of allergens, pathogens, and irritants, thus protecting the airway and contributing to immune surveillance and mucociliary clearance. Disruption of the nasal mucosal barrier leads to increased susceptibility to diseases such as allergic rhinitis and chronic rhinosinusitis. Therapeutic strategies often focus on restoring barrier integrity and function[1][3][4].
Drugs interact with the nasal mucosal barrier by restoring physical barrier components (such as tight junctions), modulating inflammation, enhancing mucociliary clearance, and supporting microbiota homeostasis.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nasal mucosal barrier.